I never bought in the high 50s as it was clearly the MC very overvalue based on the fundamental of the stock at that time, my initial small purchase was 35c which I could have flip it for a $10K profit in a few weeks but didn't as I prefer to invest in biotech start-up for massive CGT discount, bought more at 23c and at 10c but the biggest purchase was at 4c and that was before the excellent fundamental in the last 12 months.
That's why I'm very surprise the pps has dropped to below what it was 12 months ago before the excellent clinical trial update for VAXINIA, Fast Track designation, ODD and excellent clinical trial update for Azer-Cel only a few months ago. That's why if you want a very cheap stock which is prime for a massive rerate based on the fundamental, IMU is that stock given what has occurred to the pps in the last 12 months despite the strengthening of the fundamental.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)